Sex differences in heart failure

CSP Lam, C Arnott, AL Beale… - European heart …, 2019 - academic.oup.com
The overall lifetime risk of heart failure (HF) is similar between men and women, however,
there are marked sex differences in the landscape of this condition that are both important …

Sex differences in cardiovascular pathophysiology: why women are overrepresented in heart failure with preserved ejection fraction

AL Beale, P Meyer, TH Marwick, CSP Lam, DM Kaye - Circulation, 2018 - Am Heart Assoc
Consistent epidemiological data demonstrate that patients with heart failure with preserved
ejection fraction (HFpEF) are more likely to be women than men. Exploring mechanisms …

How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association …

B Pieske, C Tschöpe, RA De Boer… - European heart …, 2019 - academic.oup.com
Making a firm diagnosis of chronic heart failure with preserved ejection fraction (HFpEF)
remains a challenge. We recommend a new stepwise diagnostic process, the 'HFA–PEFF …

Sex differences in heart failure with preserved ejection fraction

Y Sotomi, S Hikoso, D Nakatani, H Mizuno… - Journal of the …, 2021 - Am Heart Assoc
Background The female preponderance in heart failure with preserved ejection fraction
(HFpEF) is a distinguishing feature of this disorder, but the association of sex with degree of …

The effects of exercise on cardiovascular disease risk factors and cardiovascular physiology in rheumatoid arthritis

GS Metsios, RH Moe, M Van Der Esch… - Rheumatology …, 2020 - Springer
Cardiovascular disease (CVD) morbidity and mortality is highly prevalent in patients with
rheumatoid arthritis (RA) with debilitating effects for the individual as well as significant …

Myocardial dysfunction and heart failure in rheumatoid arthritis

E Park, J Griffin, JM Bathon - Arthritis & Rheumatology, 2022 - Wiley Online Library
Rheumatoid arthritis (RA) patients have almost twice the risk of heart failure (HF) as
individuals without RA, even with adjustment for the presence of ischemic heart disease …

Pathogenesis of ischaemic and non-ischaemic heart diseases in rheumatoid arthritis

P Błyszczuk, Z Szekanecz - RMD open, 2020 - rmdopen.bmj.com
Rheumatoid arthritis (RA) is characterised by a chronic inflammatory condition of the joints,
but the comorbidities of RA predominantly contribute to the reduced lifespan associated with …

Cardiovascular effects of biological versus conventional synthetic disease-modifying antirheumatic drug therapy in treatment-naïve, early rheumatoid arthritis

S Plein, B Erhayiem, G Fent, S Horton… - Annals of the …, 2020 - ard.bmj.com
Objectives To determine whether patients with early rheumatoid arthritis (ERA) have
cardiovascular disease (CVD) that is modifiable with disease-modifying antirheumatic drug …

Myocardial Microvascular Dysfunction in Rheumatoid Arthritis: Quantitation by 13N-Ammonia Positron Emission Tomography/Computed Tomography

I Amigues, C Russo, JT Giles, A Tugcu… - Circulation …, 2019 - Am Heart Assoc
Background: The goal of this study was to assess the prevalence of myocardial
microvascular dysfunction in rheumatoid arthritis (RA) patients without clinical …

Update on cardiovascular disease risk in patients with rheumatic diseases

RH Mackey, LH Kuller… - Rheumatic Disease …, 2018 - rheumatic.theclinics.com
Cardiovascular disease (CVD) risk is increased in rheumatoid arthritis (RA) and other
inflammatory autoimmune rheumatic diseases, which have a lifetime risk of adult onset of 1 …